An official website of the United States government.

This is not the current EPA website. To navigate to the current EPA website, please go to This website is historical material reflecting the EPA website as it existed on January 19, 2021. This website is no longer updated and links to external websites and some internal pages may not work. More information »

Toxics Release Inventory (TRI) Program

Ethylene Glycol Monobutyl Ether (EGBE) Petition

On this page:

Rule Summary

EPA has denied a petition to remove Ethylene Glycol Monobutyl Ether (EGBE) from the list of chemicals subject to reporting under section 313 of the Emergency Planning and Community Right-to-Know Act (EPCRA). EPA reviewed the available human health toxicity data and aquatic ecological toxicity data for EGBE and concluded that it can reasonably be anticipated to cause serious or irreversible chronic health effects in humans, specifically, liver toxicity and concerns for hematological effects. Therefore, EGBE does not meet the deletion criterion of EPCRA section 313(d)(3).

Rule History

On January 23, 2015, EPA received a petition from American Chemistry Council (ACC) Ethylene Glycol Ethers Panel requesting EPA to delete EGBE from the list of chemicals subject to reporting under EPCRA section 313 and section 6607 of the Pollution Prevention Act.

Additional Resources

Federal Register notice (PDF) (8 pp, 280 K, About PDF)